AKT1 and cancer: It has been reported that the PI3K/AKT pathway is activated in animal models of cancer pain, neuropathic pain, and migraine, primarily manifested by significant upregulation of AKT, PI3K, and their phosphorylated forms (p‐AKT and p‐PI3K).